Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets

Calcific Aortic Valve Disease (CAVD) is the most common heart valve disease and its incidence is expected to rise with aging population. No medical treatment so far has shown slowing progression of CAVD progression. Surgery remains to this day the only way to treat it. Effective drug therapy can onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulin, Alexia, Hego, Alexandre, Lancellotti, Patrizio, Oury, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862098/
https://www.ncbi.nlm.nih.gov/pubmed/29594151
http://dx.doi.org/10.3389/fcvm.2018.00021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862098/
https://www.ncbi.nlm.nih.gov/pubmed/29594151
http://dx.doi.org/10.3389/fcvm.2018.00021

Ejemplares similares